GSK2982772 Study in Subjects With Ulcerative Colitis

NCT02903966 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: GSK2982772
DRUG: Placebo

Sponsor

GlaxoSmithKline